(NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, emphasizes the critical need for a revolutionary, broad-spectrum, antiviral drug ...
The CDC reports no confirmed cases in the United States at this time, but they are monitoring 41 patients across the country, ...
SHELTON, CT / ACCESS Newswire / May 15, 2026 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), reports that it ...
Valley Fever, a fungal disease caused by soil-borne spores in the US Southwest, is killing approximately 1,000 Americans ...
SHELTON, CT / ACCESS Newswire / May 4, 2026 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the ...
When Gabrie Ann Nakhle was approached by the Make-A-Wish Foundation during her leukemia treatment last year, the 14-year-old knew exactly what she wanted.
Chiranjeevi Kolla, a 37-year-old Indian man, died in California after a month-long battle with Valley fever, his family said ...
14d
NanoViricides: NV-387 for The Treatment of Measles is Granted Orphan Drug Designation by The US FDA
SHELTON, CT / ACCESS Newswire / May 4, 2026 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development of br ...
SHELTON, CT / ACCESS Newswire / May 11, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, emphasizes the ...
Bank of America Global Healthcare Conference 2026 May 12, 2026 4:40 PM EDTCompany ParticipantsDarren Lehrich - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results